These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells. Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334 [TBL] [Abstract][Full Text] [Related]
3. Successful islet transplantation in BB rats without chronic immunosuppression. Chabot JA; Lau H; Reemtsma K; Hardy MA Transplant Proc; 1987 Feb; 19(1 Pt 2):974-5. PubMed ID: 3152652 [No Abstract] [Full Text] [Related]
4. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation. Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413 [No Abstract] [Full Text] [Related]
5. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats. Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220 [TBL] [Abstract][Full Text] [Related]
6. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells. Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304 [No Abstract] [Full Text] [Related]
7. No correlation between changes in lymphocyte subsets and pancreatic B cell destruction. Kuttler B; Heym S; Volk HD; Diamantstein T; Hahn HJ Horm Metab Res Suppl; 1990; 25():182-7. PubMed ID: 2088964 [No Abstract] [Full Text] [Related]
8. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity. Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197 [TBL] [Abstract][Full Text] [Related]
9. Effects of a combined antigen-cyclosporine regimen in four transplantation models. Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626 [No Abstract] [Full Text] [Related]
10. Nature of tolerance induction to peripheral (extrathymic) islet allografts. Coulombe M; Lafferty KJ; Gill RG Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624 [No Abstract] [Full Text] [Related]
11. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173 [No Abstract] [Full Text] [Related]
12. Effect of transplant site on islet allograft survival in BB rats. Woehrle MF; Markmann JF; Armstrong J; Naji A Transplant Proc; 1987 Feb; 19(1 Pt 2):925-7. PubMed ID: 3152638 [No Abstract] [Full Text] [Related]
13. A composite graft of islet plus donor lymph node cells induced donor specific tolerance in a "low responder" rat combination with class I MHC disparity. Maeda A; Ito T; Yumiba T; Ohkawa A; Uchikoshi F; Tori M; Sawai T; Nozawa M; Matsuda H Transplant Proc; 1999; 31(1-2):749-50. PubMed ID: 10083320 [No Abstract] [Full Text] [Related]
14. Allotransplantation of neonatal islets in nonimmunosuppressed normal and diabetic rats. Serie JR; Hegre OD Transplant Proc; 1987 Feb; 19(1 Pt 2):962-4. PubMed ID: 3152649 [No Abstract] [Full Text] [Related]
15. Effect of host immunomodulation on the prevention of islet allograft primary nonfunction in a murine model. Kaufman DB; Rabe FL; Platt JL; Dunn DL; Sutherland DE Transplant Proc; 1990 Apr; 22(2):857-8. PubMed ID: 2109421 [No Abstract] [Full Text] [Related]